OpenAI, Anthropic in Talks with Biotech Firms for Data Licensing Deals

Deep News12-17 23:21

To train AI models, OpenAI, Anthropic, and Alphabet have been actively seeking specialized data, engaging in discussions with startups and public companies to license datasets in fields such as genomics.

According to sources familiar with the discussions, OpenAI representatives have approached multiple firms in recent months, including life sciences diagnostics provider Revvity, accounting software firm Xero, and companies in biotech, consumer healthcare, software, and financial services, exploring potential data licensing or other collaborative arrangements.

Meanwhile, DeepMind founder Zaven Dar revealed that Anthropic, DeepMind, and Alphabet’s AI-driven drug discovery subsidiary Isomorphic Labs have also initiated talks with early-stage biotech startups regarding data licensing or partnerships.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment